Immune recovery markers in a double blind clinical trial comparing dolutegravir and raltegravir based regimens as initial therapy (SPRING-2)

• Jose-Ramon Blanco ,

  Contributed equally to this work with: Jose-Ramon Blanco, Belen Alejos

  Roles Conceptualization, Supervision, Validation, Writing – original draft, Writing – review & editing

  Affiliation Department of Infectious Diseases, Hospital San Pedro–CIBIR, Logroño (La Rioja), Spain

  ⨯
• Belen Alejos ,

  Contributed equally to this work with: Jose-Ramon Blanco, Belen Alejos

  Roles Conceptualization, Formal analysis, Methodology, Writing – original draft, Writing – review & editing

  * E-mail: balejos@isciii.es

  Affiliation Centro Nacional de Epidemiología, Instituto de Salud Carlos III, Madrid, Spain

  http://orcid.org/0000-0001-9571-6471

  ⨯
• Santiago Moreno

  Roles Conceptualization, Supervision, Writing – original draft, Writing – review & editing

  Affiliation Department of Infectious Diseases, Hospital Ramón y Cajal, Alcalá de Henares University, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain

  ⨯